242 related articles for article (PubMed ID: 24935961)
1. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
Calkin AC; Lee SD; Kim J; Van Stijn CM; Wu XH; Lusis AJ; Hong C; Tangirala RI; Tontonoz P
Circ Res; 2014 Aug; 115(4):442-9. PubMed ID: 24935961
[TBL] [Abstract][Full Text] [Related]
2. The Use of L-sIDOL Transgenic Mice as a Murine Model to Study Hypercholesterolemia and Atherosclerosis.
Zerenturk EJ; Calkin AC
Methods Mol Biol; 2017; 1583():65-72. PubMed ID: 28205167
[TBL] [Abstract][Full Text] [Related]
3. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
[TBL] [Abstract][Full Text] [Related]
4. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
5. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
6. Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.
Wang C; Nishijima K; Kitajima S; Niimi M; Yan H; Chen Y; Ning B; Matsuhisa F; Liu E; Zhang J; Chen YE; Fan J
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1282-1289. PubMed ID: 28546217
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
[TBL] [Abstract][Full Text] [Related]
8. Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.
Berbée JFP; Mol IM; Milne GL; Pollock E; Hoeke G; Lütjohann D; Monaco C; Rensen PCN; van der Ploeg LHT; Shchepinov MS
Atherosclerosis; 2017 Sep; 264():100-107. PubMed ID: 28655430
[TBL] [Abstract][Full Text] [Related]
9. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.
Hong C; Duit S; Jalonen P; Out R; Scheer L; Sorrentino V; Boyadjian R; Rodenburg KW; Foley E; Korhonen L; Lindholm D; Nimpf J; van Berkel TJ; Tontonoz P; Zelcer N
J Biol Chem; 2010 Jun; 285(26):19720-6. PubMed ID: 20427281
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice.
Wong MC; van Diepen JA; Hu L; Guigas B; de Boer HC; van Puijvelde GH; Kuiper J; van Zonneveld AJ; Shoelson SE; Voshol PJ; Romijn JA; Havekes LM; Tamsma JT; Rensen PC; Hiemstra PS; Berbée JF
Atherosclerosis; 2012 Feb; 220(2):362-8. PubMed ID: 21798539
[TBL] [Abstract][Full Text] [Related]
13. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
Krishnamurthy K; Glaser S; Alpini GD; Cardounel AJ; Liu Z; Ilangovan G
Cardiovasc Res; 2016 Jul; 111(1):74-83. PubMed ID: 27131506
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
[TBL] [Abstract][Full Text] [Related]
15. Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.
Liang C; Wang X; Peng K; Lai P; Liu Z; Ma J; Chen X; Liu G; Zheng M; Wang Y; Yang H; Liu G; Xian X; Gao M
Oxid Med Cell Longev; 2022; 2022():1889632. PubMed ID: 35656026
[TBL] [Abstract][Full Text] [Related]
16. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
[TBL] [Abstract][Full Text] [Related]
17. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome.
Liu S; Vaziri ND
Nephrol Dial Transplant; 2014 Mar; 29(3):538-43. PubMed ID: 24166456
[TBL] [Abstract][Full Text] [Related]
18. SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet.
Potì F; Ceglarek U; Burkhardt R; Simoni M; Nofer JR
Atherosclerosis; 2015 May; 240(1):212-5. PubMed ID: 25801013
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the E3 Ubiquitin Ligase IDOL Attenuates Diet-Induced Obesity and Metabolic Dysfunction in Mice.
van Loon NM; Ottenhoff R; Kooijman S; Moeton M; Scheij S; Roscam Abbing RLP; Gijbels MJJ; Levels JHM; Sorrentino V; Berbée JFP; Rensen PCN; Zelcer N
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1785-1795. PubMed ID: 29903737
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]